Skip to main content
Erschienen in: Head and Neck Pathology 2/2022

13.07.2021 | Original Paper

Malignant Transformation Rate of Non-reactive Oral Hyperkeratoses Suggests an Early Dysplastic Phenotype

verfasst von: Ivan J. Stojanov, Sook-Bin Woo

Erschienen in: Head and Neck Pathology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

The presence of epithelial dysplasia (ED) in oral leukoplakia is the single most important predictor of malignant transformation (MT). The majority of leukoplakias, however, do not show evidence of ED and yet MT of these lesions is well-recognized. These lesions have been referred to as “hyperkeratosis/hyperplasia, no dysplasia,” “keratosis of unknown significance” and “hyperkeratosis, not reactive (HkNR).” This study evaluates the MT rate of such leukoplakias. A literature review was performed to identify cohort studies on leukoplakias where (1) there was a recorded histopathologic diagnosis, (2) cases of “hyperkeratosis/hyperplasia, no dysplasia” comprised part of the cohort, and (3) follow-up information was available. There were 9,358 leukoplakias, of which 28.5% exhibited ED while 37.7% consisted of HkNR. Follow-up ranged from 15 to 73 months. The incidence of MT in leukoplakia exhibiting HkNR was 4.9%, compared to 15.3% for ED. Among oral squamous cell carcinomas (SCC) with previously biopsied, site-specific precursor lesions, 55.7% arose from ED/carcinoma in situ and 28.0% arose from HkNR. Leukoplakia exhibiting HkNR has a substantial MT rate, similar to that of mild ED, and must be recognized and managed appropriately to reduce oral SCC incidence.
Literatur
1.
Zurück zum Zitat Villa A, Woo SB. Leukoplakia-a diagnostic and management algorithm. J Oral Maxillofac Surg. 2017;75(4):723–34.PubMedCrossRef Villa A, Woo SB. Leukoplakia-a diagnostic and management algorithm. J Oral Maxillofac Surg. 2017;75(4):723–34.PubMedCrossRef
2.
Zurück zum Zitat Woo SB, Lin D. Morsicatio mucosae oris–a chronic oral frictional keratosis, not a leukoplakia. J Oral Maxillofac Surg. 2009;67(1):140–6.PubMedCrossRef Woo SB, Lin D. Morsicatio mucosae oris–a chronic oral frictional keratosis, not a leukoplakia. J Oral Maxillofac Surg. 2009;67(1):140–6.PubMedCrossRef
3.
Zurück zum Zitat Muller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol. 2017;30(s1):S54–67.PubMedCrossRef Muller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol. 2017;30(s1):S54–67.PubMedCrossRef
4.
Zurück zum Zitat Almazyad A, Li CI, Woo SB. Benign Alveolar Ridge keratosis: clinical and histopathologic analysis of 167 cases. Head and neck pathology. 2020;14:915.PubMedPubMedCentralCrossRef Almazyad A, Li CI, Woo SB. Benign Alveolar Ridge keratosis: clinical and histopathologic analysis of 167 cases. Head and neck pathology. 2020;14:915.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Lee JJ, Hung HC, Cheng SJ, Chen YJ, Chiang CP, Liu BY, et al. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(4):472–80.PubMedCrossRef Lee JJ, Hung HC, Cheng SJ, Chen YJ, Chiang CP, Liu BY, et al. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(4):472–80.PubMedCrossRef
6.
Zurück zum Zitat Woo SB, Grammer RL, Lerman MA. Keratosis of unknown significance and leukoplakia: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118(6):713–24.PubMedCrossRef Woo SB, Grammer RL, Lerman MA. Keratosis of unknown significance and leukoplakia: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118(6):713–24.PubMedCrossRef
7.
Zurück zum Zitat Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2016;45(3):155–66.PubMedCrossRef Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2016;45(3):155–66.PubMedCrossRef
8.
Zurück zum Zitat Graveland AP, Bremmer JF, de Maaker M, Brink A, Cobussen P, Zwart M, et al. Molecular screening of oral precancer. Oral Oncol. 2013;49(12):1129–35.PubMedCrossRef Graveland AP, Bremmer JF, de Maaker M, Brink A, Cobussen P, Zwart M, et al. Molecular screening of oral precancer. Oral Oncol. 2013;49(12):1129–35.PubMedCrossRef
9.
Zurück zum Zitat Brouns E, Baart J, Karagozoglu K, Aartman I, Bloemena E, van der Waal I. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 2014;20(3):e19-24.PubMedCrossRef Brouns E, Baart J, Karagozoglu K, Aartman I, Bloemena E, van der Waal I. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 2014;20(3):e19-24.PubMedCrossRef
10.
Zurück zum Zitat El-Naggar AKCJ, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumors. Lyon: IARC Press; 2017. El-Naggar AKCJ, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumors. Lyon: IARC Press; 2017.
11.
Zurück zum Zitat Dost F, Le Cao KA, Ford PJ, Farah CS. A retrospective analysis of clinical features of oral malignant and potentially malignant disorders with and without oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(6):725–33.PubMedCrossRef Dost F, Le Cao KA, Ford PJ, Farah CS. A retrospective analysis of clinical features of oral malignant and potentially malignant disorders with and without oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(6):725–33.PubMedCrossRef
12.
Zurück zum Zitat Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998;34(4):270–5.PubMedCrossRef Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998;34(4):270–5.PubMedCrossRef
13.
Zurück zum Zitat Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011;40(9):677–83.PubMedCrossRef Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011;40(9):677–83.PubMedCrossRef
14.
Zurück zum Zitat Thompson LDR, Fitzpatrick SG, Muller S, Eisenberg E, Upadhyaya JD, Lingen MW, et al. Proliferative verrucous leukoplakia: an expert consensus guideline for standardized assessment and reporting. Head Neck Pathol. 2021;15:572.PubMedPubMedCentralCrossRef Thompson LDR, Fitzpatrick SG, Muller S, Eisenberg E, Upadhyaya JD, Lingen MW, et al. Proliferative verrucous leukoplakia: an expert consensus guideline for standardized assessment and reporting. Head Neck Pathol. 2021;15:572.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45(4–5):317–23.PubMedCrossRef van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45(4–5):317–23.PubMedCrossRef
16.
Zurück zum Zitat Villa A, Hanna GJ, Kacew A, Frustino J, Hammerman PS, Woo SB. Oral keratosis of unknown significance shares genomic overlap with oral dysplasia. Oral Dis. 2019;25(7):1707–14.PubMedCrossRef Villa A, Hanna GJ, Kacew A, Frustino J, Hammerman PS, Woo SB. Oral keratosis of unknown significance shares genomic overlap with oral dysplasia. Oral Dis. 2019;25(7):1707–14.PubMedCrossRef
17.
Zurück zum Zitat Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000;6(2):357–62.PubMed Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000;6(2):357–62.PubMed
18.
Zurück zum Zitat Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42(5):461–74.PubMedCrossRef Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42(5):461–74.PubMedCrossRef
19.
Zurück zum Zitat Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med. 2007;36(1):25–9.PubMedCrossRef Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med. 2007;36(1):25–9.PubMedCrossRef
20.
Zurück zum Zitat Ho PS, Chen PL, Warnakulasuriya S, Shieh TY, Chen YK, Huang IY. Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer. 2009;9:260.PubMedPubMedCentralCrossRef Ho PS, Chen PL, Warnakulasuriya S, Shieh TY, Chen YK, Huang IY. Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer. 2009;9:260.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Wang YY, Tail YH, Wang WC, Chen CY, Kao YH, Chen YK, et al. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. BMC Oral Health. 2014;14:99.PubMedPubMedCentralCrossRef Wang YY, Tail YH, Wang WC, Chen CY, Kao YH, Chen YK, et al. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. BMC Oral Health. 2014;14:99.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Kuribayashi Y, Tsushima F, Morita KI, Matsumoto K, Sakurai J, Uesugi A, et al. Long-term outcome of non-surgical treatment in patients with oral leukoplakia. Oral Oncol. 2015;51(11):1020–5.PubMedCrossRef Kuribayashi Y, Tsushima F, Morita KI, Matsumoto K, Sakurai J, Uesugi A, et al. Long-term outcome of non-surgical treatment in patients with oral leukoplakia. Oral Oncol. 2015;51(11):1020–5.PubMedCrossRef
23.
Zurück zum Zitat Mogedas-Vegara A, Hueto-Madrid JA, Chimenos-Kustner E, Bescos-Atin C. The treatment of oral leukoplakia with the CO2 laser: a retrospective study of 65 patients. J Cranio-Maxillo-Facial Surg. 2015;43(5):677–81.CrossRef Mogedas-Vegara A, Hueto-Madrid JA, Chimenos-Kustner E, Bescos-Atin C. The treatment of oral leukoplakia with the CO2 laser: a retrospective study of 65 patients. J Cranio-Maxillo-Facial Surg. 2015;43(5):677–81.CrossRef
24.
Zurück zum Zitat Lima JS, Correa L, Klingbeil MF, de Sousa SC. c-Jun, pc-Jun, and p27 are differently expressed in oral leukoplakias in smokers and never-smokers. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(1):73–80.PubMedCrossRef Lima JS, Correa L, Klingbeil MF, de Sousa SC. c-Jun, pc-Jun, and p27 are differently expressed in oral leukoplakias in smokers and never-smokers. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(1):73–80.PubMedCrossRef
25.
Zurück zum Zitat Gandara-Vila P, Perez-Sayans M, Suarez-Penaranda JM, Gallas-Torreira M, Somoza-Martin J, Reboiras-Lopez MD, et al. Survival study of leukoplakia malignant transformation in a region of northern Spain. Medicina oral, patologia oral y cirugia bucal. 2018;23(4):e413–20.PubMedPubMedCentral Gandara-Vila P, Perez-Sayans M, Suarez-Penaranda JM, Gallas-Torreira M, Somoza-Martin J, Reboiras-Lopez MD, et al. Survival study of leukoplakia malignant transformation in a region of northern Spain. Medicina oral, patologia oral y cirugia bucal. 2018;23(4):e413–20.PubMedPubMedCentral
26.
Zurück zum Zitat Wang T, Wang L, Yang H, Lu H, Zhang J, Li N, et al. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: a large-scale cohort study. J Oral Pathol Med. 2019;48(6):491–8.PubMedCrossRef Wang T, Wang L, Yang H, Lu H, Zhang J, Li N, et al. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: a large-scale cohort study. J Oral Pathol Med. 2019;48(6):491–8.PubMedCrossRef
27.
Zurück zum Zitat Wu W, Wang Z, Zhou Z. Risk factors associated with malignant transformation in patients with oral leukoplakia in a Chinese population: a retrospective study. J Oral Maxillofac Surg. 2019;77(12):2483–93.PubMedCrossRef Wu W, Wang Z, Zhou Z. Risk factors associated with malignant transformation in patients with oral leukoplakia in a Chinese population: a retrospective study. J Oral Maxillofac Surg. 2019;77(12):2483–93.PubMedCrossRef
28.
Zurück zum Zitat Sakata J, Yoshida R, Matsuoka Y, Kawahara K, Arita H, Nakashima H, et al. FOXP3 lymphocyte status may predict the risk of malignant transformation in oral leukoplakia. J Oral Max Surg Med. 2020;32(1):33–9. Sakata J, Yoshida R, Matsuoka Y, Kawahara K, Arita H, Nakashima H, et al. FOXP3 lymphocyte status may predict the risk of malignant transformation in oral leukoplakia. J Oral Max Surg Med. 2020;32(1):33–9.
29.
Zurück zum Zitat Jayasooriya PR, Dayaratne K, Dissanayake UB, Warnakulasuriya S. Malignant transformation of oral leukoplakia: a follow-up study. Clin Oral Investig. 2020;24(12):4563–9.PubMedCrossRef Jayasooriya PR, Dayaratne K, Dissanayake UB, Warnakulasuriya S. Malignant transformation of oral leukoplakia: a follow-up study. Clin Oral Investig. 2020;24(12):4563–9.PubMedCrossRef
30.
Zurück zum Zitat Li J, Liu Y, Zhang H, Hua H. Association between hyperglycemia and the malignant transformation of oral leukoplakia in China. Oral Dis. 2020;26:1402.PubMedCrossRef Li J, Liu Y, Zhang H, Hua H. Association between hyperglycemia and the malignant transformation of oral leukoplakia in China. Oral Dis. 2020;26:1402.PubMedCrossRef
31.
Zurück zum Zitat Goodson ML, Sloan P, Robinson CM, Cocks K, Thomson PJ. Oral precursor lesions and malignant transformation: who, where, what, and when? Br J Oral Maxillofac Surg. 2015;53(9):831–5.PubMedCrossRef Goodson ML, Sloan P, Robinson CM, Cocks K, Thomson PJ. Oral precursor lesions and malignant transformation: who, where, what, and when? Br J Oral Maxillofac Surg. 2015;53(9):831–5.PubMedCrossRef
32.
Zurück zum Zitat Chaturvedi AK, Udaltsova N, Engels EA, Katzel JA, Yanik EL, Katki HA, et al. Oral leukoplakia and risk of progression to oral cancer: A population-based cohort study. J Natl Cancer Inst. 2019;112:1047.PubMedCentralCrossRef Chaturvedi AK, Udaltsova N, Engels EA, Katzel JA, Yanik EL, Katki HA, et al. Oral leukoplakia and risk of progression to oral cancer: A population-based cohort study. J Natl Cancer Inst. 2019;112:1047.PubMedCentralCrossRef
33.
Zurück zum Zitat Barnes EL. Diseases of the larynx, hypopharynx and esophagus. In: Surgical Pathology of the Head and Neck. Marcel Dekker: New York, pp 127–237. 2001. Barnes EL. Diseases of the larynx, hypopharynx and esophagus. In: Surgical Pathology of the Head and Neck. Marcel Dekker: New York, pp 127–237. 2001.
34.
Zurück zum Zitat Wenig BM. Squamous cell carcinoma of the upper aerodigestive tract: dysplasia and select variants. Mod Pathol. 2017;30(s1):S112–8.PubMedCrossRef Wenig BM. Squamous cell carcinoma of the upper aerodigestive tract: dysplasia and select variants. Mod Pathol. 2017;30(s1):S112–8.PubMedCrossRef
35.
Zurück zum Zitat Sperandio M, Brown AL, Lock C, Morgan PR, Coupland VH, Madden PB, et al. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders. Cancer Prev Res. 2013;6(8):822–31.CrossRef Sperandio M, Brown AL, Lock C, Morgan PR, Coupland VH, Madden PB, et al. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders. Cancer Prev Res. 2013;6(8):822–31.CrossRef
36.
Zurück zum Zitat Isenberg JS, Crozier DL, Dailey SH. Institutional and comprehensive review of laryngeal leukoplakia. Ann Otol Rhinol Laryngol. 2008;117(1):74–9.PubMedCrossRef Isenberg JS, Crozier DL, Dailey SH. Institutional and comprehensive review of laryngeal leukoplakia. Ann Otol Rhinol Laryngol. 2008;117(1):74–9.PubMedCrossRef
37.
Zurück zum Zitat Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008;37(3):127–33.PubMedCrossRef Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008;37(3):127–33.PubMedCrossRef
38.
Zurück zum Zitat Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia—a systematic review and meta-analysis. Head Neck. 2009;31(12):1600–9.PubMedCrossRef Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia—a systematic review and meta-analysis. Head Neck. 2009;31(12):1600–9.PubMedCrossRef
39.
Zurück zum Zitat Dost F, Le Cao K, Ford PJ, Ades C, Farah CS. Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(3):343–52.PubMedCrossRef Dost F, Le Cao K, Ford PJ, Ades C, Farah CS. Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(3):343–52.PubMedCrossRef
40.
Zurück zum Zitat Li CC, Almazrooa S, Carvo I, Salcines A, Woo SB. Architectural alterations in oral epithelial dysplasia are similar in unifocal and proliferative leukoplakia. Head Neck Pathol. 2020;15:443.PubMedPubMedCentralCrossRef Li CC, Almazrooa S, Carvo I, Salcines A, Woo SB. Architectural alterations in oral epithelial dysplasia are similar in unifocal and proliferative leukoplakia. Head Neck Pathol. 2020;15:443.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Wils LJ, Poell JB, Evren I, Koopman MS, Brouns E, de Visscher J, et al. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression. Mod Pathol. 2020;33(6):1033–40.PubMedPubMedCentralCrossRef Wils LJ, Poell JB, Evren I, Koopman MS, Brouns E, de Visscher J, et al. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression. Mod Pathol. 2020;33(6):1033–40.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol. 2000;24(3):429–41.PubMedCrossRef Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol. 2000;24(3):429–41.PubMedCrossRef
44.
Zurück zum Zitat Hoang LN, Park KJ, Soslow RA, Murali R. Squamous precursor lesions of the vulva: current classification and diagnostic challenges. Pathology. 2016;48(4):291–302.PubMedCrossRef Hoang LN, Park KJ, Soslow RA, Murali R. Squamous precursor lesions of the vulva: current classification and diagnostic challenges. Pathology. 2016;48(4):291–302.PubMedCrossRef
45.
Zurück zum Zitat Cowan CG, Gregg TA, Napier SS, McKenna SM, Kee F. Potentially malignant oral lesions in Northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis. 2001;7(1):18–24.PubMed Cowan CG, Gregg TA, Napier SS, McKenna SM, Kee F. Potentially malignant oral lesions in Northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis. 2001;7(1):18–24.PubMed
46.
Zurück zum Zitat Vogelstein B, Kinzler KW. The path to cancer—three strikes and you’re out. N Engl J Med. 2015;373(20):1895–8.PubMedCrossRef Vogelstein B, Kinzler KW. The path to cancer—three strikes and you’re out. N Engl J Med. 2015;373(20):1895–8.PubMedCrossRef
47.
Zurück zum Zitat Arnaoutakis D, Bishop J, Westra W, Califano JA. Recurrence patterns and management of oral cavity premalignant lesions. Oral Oncol. 2013;49(8):814–7.PubMedCrossRef Arnaoutakis D, Bishop J, Westra W, Califano JA. Recurrence patterns and management of oral cavity premalignant lesions. Oral Oncol. 2013;49(8):814–7.PubMedCrossRef
Metadaten
Titel
Malignant Transformation Rate of Non-reactive Oral Hyperkeratoses Suggests an Early Dysplastic Phenotype
verfasst von
Ivan J. Stojanov
Sook-Bin Woo
Publikationsdatum
13.07.2021
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 2/2022
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-021-01363-z

Weitere Artikel der Ausgabe 2/2022

Head and Neck Pathology 2/2022 Zur Ausgabe

Sine qua non Clinicopathologic Correlat

Lingual Choristoma with Gastric Epithelium Revisited

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …